Crispr Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.5M | 75k | 46.98 |
| 2024-06-30 | $4.3M | 79k | 54.01 |
| 2024-03-31 | $5.1M | 75k | 68.16 |
| 2023-12-31 | $6.8M | 108k | 62.60 |
| 2023-09-30 | $4.8M | 105k | 45.39 |
| 2023-06-30 | $6.1M | 108k | 56.14 |
| 2023-03-31 | $4.9M | 109k | 45.23 |
| 2022-12-31 | $3.2M | 109k | 29.00 |
| 2022-09-30 | $0 | 118k | 0.00 |
| 2022-06-30 | $6.2M | 102k | 60.57 |
| 2022-03-31 | $5.7M | 91k | 62.63 |
| 2021-12-31 | $4.9M | 65k | 75.71 |
| 2021-09-30 | $7.0M | 62k | 112.14 |
| 2021-06-30 | $9.9M | 61k | 161.89 |
| 2021-03-31 | $5.5M | 45k | 121.85 |
| 2020-12-31 | $6.1M | 40k | 153.11 |
| 2020-09-30 | $20M | 240k | 83.65 |
| 2020-06-30 | $0 | 224k | 0.00 |
| 2020-03-31 | $8.9M | 209k | 42.42 |
| 2019-12-31 | $2.8M | 46k | 60.91 |
| 2019-09-30 | $1.6M | 39k | 40.98 |
| 2019-06-30 | $1.6M | 33k | 47.10 |
| 2019-03-31 | $546k | 15k | 35.71 |
| 2018-12-31 | $493k | 17k | 28.57 |
| 2018-09-30 | $1.5M | 35k | 44.32 |
| 2018-06-30 | $1.8M | 31k | 58.73 |
| 2018-03-31 | $996k | 22k | 45.73 |